IL109376A - Pharmaceutical composition containing (R)-5-(methyl-aminosulfonylmethyl)-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole and (R)-5-(methylamino-sulfonylmethyl)-3-(pyrrolidin-2-ylmethyl)-1H-indole - Google Patents

Pharmaceutical composition containing (R)-5-(methyl-aminosulfonylmethyl)-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole and (R)-5-(methylamino-sulfonylmethyl)-3-(pyrrolidin-2-ylmethyl)-1H-indole

Info

Publication number
IL109376A
IL109376A IL10937694A IL10937694A IL109376A IL 109376 A IL109376 A IL 109376A IL 10937694 A IL10937694 A IL 10937694A IL 10937694 A IL10937694 A IL 10937694A IL 109376 A IL109376 A IL 109376A
Authority
IL
Israel
Prior art keywords
indole
methyl
aminosulfonylmethyl
sulfonylmethyl
methylpyrrolidin
Prior art date
Application number
IL10937694A
Other languages
English (en)
Other versions
IL109376A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL109376A0 publication Critical patent/IL109376A0/xx
Publication of IL109376A publication Critical patent/IL109376A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IL10937694A 1993-04-27 1994-04-21 Pharmaceutical composition containing (R)-5-(methyl-aminosulfonylmethyl)-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole and (R)-5-(methylamino-sulfonylmethyl)-3-(pyrrolidin-2-ylmethyl)-1H-indole IL109376A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5393093A 1993-04-27 1993-04-27

Publications (2)

Publication Number Publication Date
IL109376A0 IL109376A0 (en) 1994-07-31
IL109376A true IL109376A (en) 2000-10-31

Family

ID=21987528

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10937694A IL109376A (en) 1993-04-27 1994-04-21 Pharmaceutical composition containing (R)-5-(methyl-aminosulfonylmethyl)-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole and (R)-5-(methylamino-sulfonylmethyl)-3-(pyrrolidin-2-ylmethyl)-1H-indole

Country Status (29)

Country Link
EP (1) EP0696194B1 (no)
JP (1) JP2922307B2 (no)
KR (1) KR960701636A (no)
CN (3) CN1515252A (no)
AP (1) AP486A (no)
AT (1) ATE222492T1 (no)
AU (1) AU689469B2 (no)
BG (1) BG61898B1 (no)
BR (1) BR9406435A (no)
CA (1) CA2161533C (no)
CO (1) CO4230093A1 (no)
CZ (1) CZ290416B6 (no)
DE (1) DE69431201T2 (no)
DK (1) DK0696194T3 (no)
ES (1) ES2180573T3 (no)
HU (1) HU222488B1 (no)
IL (1) IL109376A (no)
MX (1) MX9403088A (no)
NO (1) NO308236B1 (no)
NZ (1) NZ263614A (no)
OA (1) OA10189A (no)
PL (1) PL175156B1 (no)
PT (1) PT696194E (no)
RO (1) RO117760B1 (no)
RU (1) RU2132683C1 (no)
SG (1) SG43951A1 (no)
SK (1) SK283353B6 (no)
WO (1) WO1994025023A1 (no)
ZA (1) ZA942805B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
AU686654B2 (en) * 1993-08-31 1998-02-12 Pfizer Inc. 5-arylindole derivatives
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
ATE224388T1 (de) * 1994-10-12 2002-10-15 Pfizer Res & Dev Indolderivate zur behandlung von migräne
GB9424471D0 (en) * 1994-12-03 1995-01-18 Pfizer Ltd Treatment of emesis
GB9510223D0 (en) * 1995-05-20 1995-07-19 Pfizer Ltd Therapeutic agent
US5945118A (en) * 1995-09-29 1999-08-31 Pfizer Inc Indole derivative for the treatment of migraine
US5773015A (en) * 1996-11-27 1998-06-30 Elizabeth Arden Co., Division Of Conopco, Inc. Method for controlling skin oils and grease
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
KR20220137085A (ko) * 2020-02-04 2022-10-11 마인드셋 파마 인크. Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 3-피롤리딘-인돌 유도체

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103770D0 (en) * 1991-02-22 1991-04-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
EP0696194A1 (en) 1996-02-14
RU2132683C1 (ru) 1999-07-10
RO117760B1 (ro) 2002-07-30
DE69431201T2 (de) 2002-12-05
NO954287D0 (no) 1995-10-26
AP9400633A0 (en) 1994-04-30
SK283353B6 (sk) 2003-06-03
HUT73670A (en) 1996-09-30
ES2180573T3 (es) 2003-02-16
NO954287L (no) 1995-10-26
CZ9502802A3 (en) 1996-04-17
CN1121689A (zh) 1996-05-01
HU222488B1 (hu) 2003-07-28
AU6436094A (en) 1994-11-21
IL109376A0 (en) 1994-07-31
HU9503089D0 (en) 1995-12-28
ZA942805B (en) 1995-10-23
CO4230093A1 (es) 1995-10-19
NZ263614A (en) 1998-02-26
WO1994025023A1 (en) 1994-11-10
PL311266A1 (en) 1996-02-05
MX9403088A (es) 1997-02-28
JP2922307B2 (ja) 1999-07-19
BR9406435A (pt) 1996-01-09
CZ290416B6 (cs) 2002-07-17
DE69431201D1 (de) 2002-09-26
PL175156B1 (pl) 1998-11-30
CN1515252A (zh) 2004-07-28
AP486A (en) 1996-04-16
PT696194E (pt) 2002-11-29
ATE222492T1 (de) 2002-09-15
DK0696194T3 (da) 2002-10-07
BG100093A (bg) 1996-04-30
KR960701636A (ko) 1996-03-28
NO308236B1 (no) 2000-08-21
OA10189A (en) 1996-12-18
SG43951A1 (en) 1997-11-14
AU689469B2 (en) 1998-04-02
EP0696194B1 (en) 2002-08-21
CN1509713A (zh) 2004-07-07
JPH08504829A (ja) 1996-05-28
SK133295A3 (en) 1997-01-08
CA2161533C (en) 1998-08-04
CA2161533A1 (en) 1994-11-10
BG61898B1 (bg) 1998-09-30

Similar Documents

Publication Publication Date Title
HUT75648A (en) 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and pharmaceutical compositions containing them
IL114622A (en) 5-membered heteroaryl-oxazolidinones and pharmaceutical compositions containing them
IL110743A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
PH25185A (en) Substituted pyrroles and pharmaceutical composition containing said compounds
CZ99396A3 (en) Macrolide compounds and pharmaceutical composition containing thereof
IL111785A0 (en) Dp-iv inhibitors and pharmaceutical compositions containing them
IL114626A (en) 6-membered nitrogen-containing heteroaryl-oxazolidinones and pharmaceutical compositions containing them
HU9403491D0 (en) Thiazolidine derivatives and pharmaceutical composition containing the same
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
IL110296A0 (en) Imidazole compounds and pharmaceutical compositions containing them
IL104824A0 (en) Heterobicyclic compounds and pharmaceutical compositions containing them
IL111221A0 (en) N-alkyl-n- arylpyrimidinamine derivatives and pharmaceutical compositions containing them
HU9402974D0 (en) Pharmaceutical composition
HU9600813D0 (en) Azole derivatives and pharmaceutical composition thereof
IL109376A (en) Pharmaceutical composition containing (R)-5-(methyl-aminosulfonylmethyl)-3-(N-methylpyrrolidin-2-yl-methyl)-1H-indole and (R)-5-(methylamino-sulfonylmethyl)-3-(pyrrolidin-2-ylmethyl)-1H-indole
IL110988A0 (en) 4-arylamino-benzopyran derivatives and pharmaceutical compositions containing the same
HUP0100470A3 (en) Oxazolidinone derivatives and pharmaceutical compositions containing them
HUP9901452A3 (en) Bicyclic-aromatic compounds and pharmaceutical compositions containing them
HU9600427D0 (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
EG23781A (en) Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
PL314036A1 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees